Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 05, 2004 09:42 ET | Source: SkyePharma PLC

GlaxoSmithKline Licenses SkyePharma Formulation Technology for Respiratory Drugs

LONDON, Jan. 5, 2004 (PRIMEZONE) -- SkyePharma PLC (LSE:SKP) (Nasdaq:SKYE) today announced a licence agreement with GlaxoSmithKline (LSE:GSK) (NYSE:GSK) to provide access to one of SkyePharma's...
January 05, 2004 09:35 ET | Source: SkyePharma PLC

SkyePharma PLC Provides End-2003 Trading Update

LONDON, Jan. 5, 2004 (PRIMEZONE) -- SkyePharma PLC (Nasdaq:SKYE) (LSE:SKP) announces a Trading Update for the year ending 31 December 2003. As a result of delays in concluding a number of key deals...
October 20, 2003 02:33 ET | Source: SkyePharma PLC

SkyePharma Welcomes FDA Approval of Additional Indication for Paxil CR

LONDON, Oct. 20, 2003 (PRIMEZONE) -- SkyePharma PLC (Nasdaq:SKYE) (LSE:SKP) welcomes the recent announcement by its partner GlaxoSmithKline (NYSE:GSK), that the US Food & Drug Administration...
October 17, 2003 12:27 ET | Source: SkyePharma PLC

SkyePharma PLC -- Director Shareholding

LONDON, Oct. 17, 2003 (PRIMEZONE) -- SkyePharma PLC ("the Company") (Nasdaq:SKYE) (LSE:SKP): As previously disclosed in the Company's Annual Report 2002, Mr Gowrie-Smith, Executive Chairman, had...
April 10, 2002 03:03 ET | Source: SkyePharma PLC

SkyePharma Preliminary Results Presentation

LONDON, April 10, 2002 (PRIMEZONE) -- SkyePharma plc (Nasdaq:SKYE): Log on to www.cantos.com to watch Michael Ashton (CEO) and Donald Nicholson (CFO) give their presentation and discuss: -...